Compare Adaptive Biotechnologies Corp (ADPT) vs AngloGold Ashanti Limited (AU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs AngloGold Ashanti Limited — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while AngloGold Ashanti Limited trades at $101.15 (market cap $49.28B). The key difference: AngloGold Ashanti Limited is far larger — about 12.2× Adaptive Biotechnologies Corp's market cap, and AngloGold Ashanti Limited pays a 4.64% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | AU | |
|---|---|---|
Market Cap | $4.04B | $49.28B |
Sector | Health | Basic Materials |
52-Week High | $25.45 | $128.26 |
52-Week Low | $12.30 | $52.15 |
Enterprise Value | $4.10B | $48.29B |
Dividend Yield | — | 4.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About AngloGold Ashanti Limited
Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
Read more on AU →
